Skip to content

Evaluation of the Possible Effect of Inspiratory Muscle Training on Inflammation Markers and Oxidative Stress in Childhood Asthma

Evaluation of the Possible Effect of Inspiratory Muscle Training on Inflammation Markers and Oxidative Stress in Childhood Asthma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05296707
Enrollment
105
Registered
2022-03-25
Start date
2019-03-01
Completion date
2020-06-30
Last updated
2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma in Children, Children, Adult

Keywords

Childhood Asthma, Inspiratory Muscle Training, Inflammation

Brief summary

As inflammation and oxidative stress increase in asthma patients, the severity of symptoms and clinical findings increase. Therefore, this study was planned to evaluate the possible effect of inspiratory muscle training (IMT) on inflammation markers and oxidative stress in childhood asthma. The study included asthma patient; 35 routine medication, 35 drug therapy and inspiratory muscle training (IMT), and 35 healthy total 105 children aged 8-17 years. Demographic information and hemogram values were recorded. Functional capacity was evaluated with the 6-minute walking test, quality of life PedsQL, respiratory muscle strength oral pressure measuring device, respiratory function test, dyspnea severity with Modified Borg Scale. C-Reactive Protein (CRP), Periostin, Transforming Growth Factor-βeta (TGF-β), Total Antioxidant Status (TAS), Total Oxidant Status (TOS), Oxidative Stress Index (OSI) were analyzed. IMT was given with a Threshold IMT device for 7 days/6 weeks at 30% of maximal inspiratory pressure, and then a second evaluation was made.

Interventions

OTHERInspiratory muscle training

The MIP/MEP value of the group that will receive inspiratory muscle training was determined and Threshold IMT training was given with 30%. In the training, the subjects were asked to sit in a relaxed position with their upper chest and shoulders relaxed. After the nose clip was attached, the children were asked to inhale and exhale by tightly closing the mouthpiece of the instrument with their lips. A 30-minute training session was carried out for 6 weeks, with 10-15 repetitive breathing apparatus and 5-10 seconds rest breaks every day.

OTHERUsed routine medicine

After the first evaluation was made, a second evaluation was made after 6 weeks of follow-up.

OTHERControl group

A healthy child compatible with the age and sex of the patient group was evaluated once.

Sponsors

Mustafa Kemal University
CollaboratorOTHER
Ege University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized clinical trial

Eligibility

Sex/Gender
ALL
Age
8 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Have been diagnosed with asthma, * Between the ages of 8-17, * No asthma attack, * Cooperating with the study, * Without cerebral palsy, mental retardation or any other major neurological diagnosis, * Agreeing to participate in the study, * Cases whose medication has not been changed for at least three weeks.

Exclusion criteria

* Presence of kyphoscoliosis that may affect respiration, * Having advanced postural alignment problem, * Having mental problems, * Having neuromuscular disease, * Making changes in the medications used in the last three weeks, * Presence of inflammatory diseases such as juvenile idiopathic arthritis.

Design outcomes

Primary

MeasureTime frameDescription
Inflammatory marker6 weeksWe assessed C reaktive protein from Blood sample
Oxidative stress6 weeksWe assessed Total oxidative level.

Secondary

MeasureTime frameDescription
Pulmonary function test6 weeksPulmonary function test was measured with a portable MiniSpirobank device
Respiratory muscle strength6 weeksRespiratory muscle strength was measured using a portable (micro RPM brand) electronic mouth pressure measuring device according to ATS/ERS criteria
functional capacity6 weeksfunctional capacity was assessed 6 MWT
Quality life6 weeksQuality life was assessed PedsQl

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026